
3 Women Reshaping Ireland's Future: From Injustice To Innovation
As Women's History Month draws to a close, Ireland, a nation still navigating the tensions between its traditional Catholic roots and its progressive modern identity, continues to face gender gaps in pay, leadership, and representation. Yet something distinct is happening. In recent years, Irish women have undergone a cultural reckoning, reclaiming space in national narratives, challenging long-held social norms, and refusing to stay silent about the injustices still embedded in daily life.
Among them, three women stand out for the scale, depth, and urgency of their work. Dr. Katriona O'Sullivan, Aoibheann O'Brien, and Natasha O'Brien drive transformative efforts across education, sustainability, and justice. Their leadership is not built on legacy or access but forged from lived experience, driven by data, and powered by a refusal to accept systems that fail the people they claim to serve.
When Dr. Katriona O'Sullivan walks into a room, she's not seeking charity; she's demanding recognition. A former teenage mother who left school at 15 and battled homelessness and addiction, O'Sullivan beat the odds to become a senior academic at Maynooth University and one of Ireland's most outspoken advocates for educational equity. But she doesn't want her story to be an exception; she wants to make it a blueprint. "Having less money is not the same as being poor," she says. "Poverty is about a lack of choices, power, dignity."
In Ireland, just 9% of students from disadvantaged backgrounds enter STEM fields compared to 25% from higher-income families. O'Sullivan's mission is to close that gap. She's connecting girls from underrepresented communities with training, mentorship, and job opportunities through her STEM-Passport for Inclusion program, which was developed in partnership with the government and nearly 200 companies, such as Microsoft. Nearly 7,000 girls have participated so far, with a target of 11,000 by 2027.
"We're in a national talent crisis, and yet we're throwing away the potential of girls living in poverty," she says. "That's not just unjust. It's short-sighted."
Dr Katriona O'Sullivan pictured with students from STEM Passport for Inclusion programme at ... More Microsoft Dublin November 2024
For O'Sullivan, the work goes beyond numbers. It's about reshaping cultural perceptions. "Disadvantage doesn't mean deficiency," she says. It means you've had to become fluent in resilience, hustle, and adaptation. To me, that is excellence."
Yet she knows that policy alone won't change hearts and minds. That's why O'Sullivan shares that she continues to speak boldly, demand more, and tell the truth about what it takes to overcome socio-economic bias. "Talent is everywhere. Opportunity isn't," she shares. "That's the gap I'm trying to close. I want to create an Ireland where a girl like me doesn't have to beat the odds to thrive—because the odds are finally on her side."
Aoibheann O'Brien returned to recession-weary Dublin in 2012 with a question: how can a country throw away tons of food while so many go hungry? The result was FoodCloud, a tech-driven social enterprise transforming how Ireland handles food waste and food insecurity.
FoodCloud Co-founders Aoibheann O'Brien and Iseult Ward host UN FAO Director-General, QU Dongyu, and ... More his team In Dublin Hub June 2024
"I was working in banking in London and saw these amazing food-sharing initiatives emerging — in Dublin, there was nothing," she says. "It started with one market and mission: connect surplus food to people who need it. But we knew from day one that charity alone wasn't enough. This had to scale."
Globally, one-third of all food produced is wasted, contributing 8–10% of total greenhouse gas emissions. In Ireland alone, an estimated 750,000 tonnes of food is wasted annually (enough to feed every person in Ireland three meals a day for more than three months).
FoodCloud's digital platform now connects over 500 retail stores and 200 food producers to 650 charities across Ireland, enabling the redistribution of surplus food that would otherwise be wasted. Their platform, FOODIVERSE, operates in six countries, from the UK to Kenya. "We've redistributed the equivalent of 340 million meals," says O'Brien. "Our goal is to hit one billion meals by 2030 — not by scaling endlessly ourselves, but by helping others do what we've done faster and better. It's about using what we've built — all the sweat and years of work to help others leapfrog," she says.
"Food waste isn't just a climate issue or a supply chain glitch — it's a massive systems failure," O'Brien continues. "And what's powerful is that tackling it has immediate, measurable social impact. Today, people are eating meals made from the food we rescued yesterday — and that same action is reducing emissions for the future."
The organization also partners with Harvard University and other institutions to embed food redistribution into national and international policy frameworks. But while the ambition is global, the heart of the mission remains local. "We imagine a world where Ireland becomes the world's first zero food waste country," she says. "And if we do, it won't be because we treated food as waste — it'll be because we treated it as worth."
Natasha O'Brien never set out to lead a movement. But after surviving a violent physical attack and watching her assailant walk free despite overwhelming evidence—she became the voice of a nation demanding change. "The system didn't fail me," she says. "It functioned exactly as it was designed—to protect the offender, not the victim."
Over 1,000 people who gathered in support of assault victim Natasha O'Brien at a protest in her home ... More city of Limerick to show solidarity. Picture: Olena Oleksienko/ilovelimerick
In June 2024, her attacker, a serving soldier, received a suspended sentence despite CCTV footage, eyewitness testimony, and text messages confirming intent. The ruling ignited public outrage. Within days, protests erupted across Ireland—thousands marched holding signs that read 'Her Name Is Natasha.'
What began as one woman's pursuit of justice quickly became something more significant: a national reckoning with how Ireland's justice system treats victims of violence—and how it responds when those victims speak out. At the center stood O'Brien. Unflinching. Unapologetic. Her story forced the country to confront a flawed legal system and the cultural discomfort with women who challenged it. As journalist Justine McCarthy observed, 'Ireland loves its strong women—as long as they're dead or never lived at all.' Natasha O'Brien shattered this tradition. She stood defiant and shouted loud against a system she felt tried to make her, and so many other women invisible.
Her successful appeal resulted in a new sentence, but for O'Brien, her work was just beginning. She is now collaborating with criminologists and advising Irish policymakers on legislative reform around sentencing, victim protection, and judicial accountability. O'Brien's leadership is reshaping more than policy. It's shifting Ireland's cultural conversation about power, safety, and whose voices are heard. 'The Ireland I'm fighting for is one where silence isn't the cost of survival, and justice doesn't have to be earned.'
In a moment when global conversations about equity are growing more polarized, these three women prioritize substance over symbolism. Though working in different spheres, their approaches are committed to identifying structural problems, applying evidence-based solutions, and rethinking accountability.
While Ireland grapples with its legacy of inequality, these women stand out not by simply seeking acknowledgment, but by fundamentally reshaping leadership itself. They refuse to be relegated to historical footnotes or to wait for permission to create change. As Women's History Month concludes, their work clearly embodies not just Ireland's history or current reality, but hope for a more equitable future.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
3 hours ago
- Forbes
STEM Toys: Higher Education Becomes Child's Play
Growing up in mid-century America school was about work, often drudgery. Play happened on playgrounds except for those of us 'visiting' the principal's office. Today, with the advent of STEM learning, play found its way into classrooms and after class clubs. STEM (Science, Technology, Engineering, Mathematics) and STEAM (adding Arts) has a rich and fascinating history that reflects shifts in education, technology, and cultural values, and traces back to the Morrill Act of 1862. The STEM movement gained thrust in the 1950's with the advent of the 'space race' and inauguration of the National Aeronautics and Space Administration (NASA) in 1958. The scientific achievements of the next three decades from the moon landing, the artificial heart, personal computing, and cell phones all yielded a call for enhanced science education. From SMET to STEM to STEAM The call was answered by the National Science Foundation (NSF) which established guidelines for the teaching of science, math, engineering, and technology in grades K-12, introducing the acronym SMET. However, educators and policymakers found the term awkward and unappealing — even suggesting it sounded like 'smut.' So, in 2001 the NSF officially rebranded the initiative STEM, and more recently STEAM, as 'Art' was added. The early twentieth century spawned three iconic toys promoting interest in engineering including the Erector Set (1913), Tinker Toys (1914), and Lincoln Logs (1916). The latter, invented by John Lloyd Wright, son of the architect Frank Lloyd Wright, were among the first toys to be marketed to both boys and girls selling over one hundred million sets worldwide. By the 1950's plastics began to populate the toy chest expanding access to educational play, aka 'edutainment.' This was brought home, both literally and figuratively, when my captivation over my first haircut led my father to a failed search for a toy-like barbershop kit. This set the stage for midwestern entrepreneurs and twin-brothers Al and Lou Stein (my father and uncle) to file patent and trademark application for 'Hippity Hop Barber Shop,' a life-like six-piece plastic barber shop play kit. In 1951, Hippity Hop debuted at the New York Toy Fair and was featured as an 'Educational Toy for Children from Two to Twelve.' The red-white-and blue packaging boasted the toy's 'Durable, Pliable, Acetate Plastic' while stating 'HARMLESS…WILL NOT CUT HAIR.' In 1958, a relatively unknown maker of wooden toys from the town of Billund, Denmark patented and introduced modular plastic building blocks inspiring problem solving through construction. Now, 1.1 trillion 'bricks' later, LEGO is considered the most valuable toy brand on the planet while also becoming the leading STEAM product producer. It is estimated that between 20-30 percent of LEGO's over $10 billion annual sales comes from educational products widely used in classrooms, competitions, and home learning. STEAM kits began making their way into K–12 classrooms in the early 2000's. But their widespread adoption accelerated around 2010–2015, driven by federal initiatives like Educate to Innovate (2009) and 'Race to the Top' which encouraged schools to invest in STEAM resources. Besides LEGO, companies like Sphero and Thames & Kosmos began tailoring products for classroom use. Next, makerspaces and project-based learning gained traction bringing STEAM toys into elementary schools. In 2024 the market size for STEAM toys and kits was estimated to be $6 billion and is expected to more than double in a decade. The drivers behind this growth include smart STEAM kits using AI and machine learning, subscription models, and online retail. With continued STEAM market maturation, category segmentation, and broad user age range it is difficult to predict which brands will become tomorrow's leaders or laggards. That said, here's an overview of the key product categories along with STEAM sector standouts: Besides the major players, STEAM toys, kits, and teaching methodologies have spawned countless smaller niche manufacturers worldwide. Yet, 70 to 80 percent of the world's toys are still being manufactured in China, as China's infrastructure and expertise make it the go-to hub for toy manufacturing. Within China's Guangdong Province, Shenzhen is known as the 'maker's dream city' housing over 5,000 toy factories — the largest such concentration in China. The city specializes in electronic toys, STEAM kits, plush toys, and custom collectibles, serving both domestic and global markets. Some began as 'cottage industries' in homes selling to schools and school systems before gaining traction and developing wholesale distribution. I was recently introduced to one such Shenzhen based STEAM kit brand, ACEBOTT, which has a particularly fascinating backstory and one I found somewhat reminiscent of my own family's 'Hippity Hop' gambit, albeit from a more principled origin. The journey into STEAM education for ACEBOTT founder and CEO Ring Huang began with deep personal motivation. As both a mother and an educator Ring Huang was frustrated by the lack of engaging, accessible tools to instruct her students about coding and technology. That frustration sparked a mission: to create hands-on kits that would make learning STEAM fun, intuitive, and empowering for kids everywhere. Ring Huang launched ACEBOTT in 2013 with a vision of helping young learners explore the 'Code Forest'—a metaphor for the vast adventurous world of coding and innovation. Under her leadership, ACEBOTT has grown into a global brand with strong presence in classrooms, maker spaces, and homes around the world. ACEBOTT tout's a curriculum-first approach, supported by the fact that their R&D team is comprised of engineers with strong STEAM education backgrounds. Ring Haung states 'We design products from a teacher's perspective, building around what students need to learn, not just what's fun to build.' ACEBOTT offers three distinct product lines each targeting a specific audience: Their curriculum-focused education series offers a 6-year progressive STEAM system designed to align with real-world applications such as Smart Home, Transportation, and Factory, making it easy for schools to adopt. I found ACEBOTT's eco-friendly wooden materials used in their STEAM kits to be a refreshing brand differentiator. This is depicted in an online case study of a German elementary school using ACECode Blockly to explore key smart home systems in a beginner-friendly visual programming platform. ACEBOTT has a growing client base in Europe and is continuing to expand globally. STEAM brands and products are being sourced online, in big boxes stores like Walmart and Target, and through a vast network of specialty toy stores, worldwide. However, it's my belief that independent specialty toy retailers are particularly well suited to prosper in the category given their emphasis on customer service and devotion to staff training. And ASTRA can become their North Star. The American Specialty Toy Retailing Association (ASTRA) focuses on independent toy retailers and specialty manufacturers and promotes creative play and educational toys. It also offers networking, trade shows, and advocacy. Additionally, Women in Toys, Licensing & Entertainment (WIT) supports women across the toy, licensing, and entertainment industries and offers mentorship, leadership development, and industry recognition. Additionally, The Toy Association, founded in 1916 as the Toy Manufacturers of America, Inc., publishes detailed reports like 'Decoding STEAM' to help manufacturers, educators, and parents understand and promote STEAM learning through play. This makes The Toy Association not just a general industry body, but a strategic ally for companies like ACEBOTT that are deeply invested in educational impact and hands-on learning.


Business Wire
20 hours ago
- Business Wire
New Irish Healthtech Firm Phyxiom Set to Transform Asthma and COPD Management
DUBLIN--(BUSINESS WIRE)-- Phyxiom, a pioneering digital healthcare company, today announced its official launch, bringing transformative technology developed through extensive clinical research led by globally recognised respiratory specialist, Professor Richard Costello (RCSI University of Medicine and Health Sciences and Beaumont Hospital). Built upon groundbreaking studies published in Lancet Respiratory Medicine and validated by health economists, Phyxiom's platform provides clinicians with precise, real-time data to significantly enhance asthma and Chronic Obstructive Pulmonary Disease (COPD) management. Co-founded by experienced tech executive Grace O'Donnell as Chief Executive Officer and healthcare professional Elaine Mac Hale as Clinical Operations Director, along with Prof Costello, Phyxiom is a spin-out company from RCSI. Based on a strong foundational IP portfolio developed under an Enterprise Ireland (EI) Commercialisation Fund award the company has recently achieved EI High Potential Start- Up (HPSU) status. O'Donnell and Mac Hale lead Phyxiom's day-to-day operations, driving forward its mission to revolutionise respiratory healthcare through advanced digital solutions. Professor Richard Costello, Chief Medical Officer at Phyxiom and Professor of Respiratory Medicine at RCSI, explained the science behind the innovation: 'Our research, spanning over a decade, has conclusively demonstrated that digitally-informed treatment significantly reduces medication use, prevents unnecessary hospitalisations, and ultimately lowers healthcare costs. By providing clinicians with objective, real-time insights into lung function and medication adherence, Phyxiom fundamentally improves diagnosis accuracy and treatment outcomes.' Phyxiom's technology is already operational across 13 Health Service Executive (HSE) asthma clinics in Ireland, processing nearly 350 patients to date, with plans to expand further and engage Irish private health insurers in 2025. Grace O'Donnell, CEO, said: 'Elaine and I are incredibly proud to lead this exciting RCSI spin-out company into the commercial market. We are passionate about using Richard's groundbreaking research as the foundation to deliver transformative, patient-centric healthcare solutions, significantly improving quality of life for patients suffering from uncontrolled asthma and COPD.' Elaine Mac Hale, Clinical Operations Director, added: 'Phyxiom seamlessly integrates into existing healthcare systems, ensuring minimal disruption to clinicians' workflows. Our evidence-based approach empowers healthcare providers with the insights needed to deliver personalised, effective, and efficient patient care.' Following its successful Irish rollout, Phyxiom is expanding into the UK market in H1 2026 and plans a US launch in 2027, supported by established partnerships and integration with leading electronic health record systems. Phyxiom's launch marks a significant milestone in Ireland's healthtech landscape, highlighting Irish innovation on the global healthcare stage. Those interested in learning more about Phyxiom, can visit the website here: About RCSI University of Medicine and Health Sciences RCSI University of Medicine and Health Sciences is ranked first in the world for its contribution to UN Sustainable Development Goal 3, Good Health and Well-being, in the Times Higher Education (THE) University Impact Rankings 2025. Founded in 1784 as the Royal College of Surgeons in Ireland with responsibility for training surgeons in Ireland, today RCSI is an innovative, not-for-profit, international university exclusively focused on driving improvements in human health worldwide through education, research and engagement. RCSI is among the top 300 universities worldwide in the World University Rankings (2025) and has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education. In 2026, RCSI will open a new public engagement space, dedicated to health and well-being, at 118 St Stephen's Green in Dublin city centre. The space is designed to engage the public in dialogue about living longer, healthier and happier lives through dynamic events and exhibitions. Our aim is to bridge the gap between health sciences research, professional expertise, and public understanding, empowering people to make informed decisions about their health. Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.
Yahoo
5 days ago
- Yahoo
10x Genomics (NASDAQ:TXG) Reports Upbeat Q2, Stock Soars
Biotech company 10x Genomics (NASDAQ:TXG) beat Wall Street's revenue expectations in Q2 CY2025, with sales up 12.9% year on year to $172.9 million. On the other hand, next quarter's revenue guidance of $142 million was less impressive, coming in 1.5% below analysts' estimates. Its GAAP profit of $0.28 per share was significantly above analysts' consensus estimates. Is now the time to buy 10x Genomics? Find out in our full research report. 10x Genomics (TXG) Q2 CY2025 Highlights: Revenue: $172.9 million vs analyst estimates of $139.5 million (12.9% year-on-year growth, 24% beat) EPS (GAAP): $0.28 vs analyst estimates of -$0.37 (significant beat) Revenue Guidance for Q3 CY2025 is $142 million at the midpoint, below analyst estimates of $144.2 million Operating Margin: 17.4%, up from -27.3% in the same quarter last year Market Capitalization: $1.58 billion Company Overview Founded in 2012 by scientists seeking to overcome limitations in traditional biological research methods, 10x Genomics (NASDAQ:TXG) develops instruments, consumables, and software that enable researchers to analyze biological systems at single-cell resolution and spatial context. Revenue Growth A company's long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, 10x Genomics grew its sales at an impressive 20.7% compounded annual growth rate. Its growth beat the average healthcare company and shows its offerings resonate with customers. Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. 10x Genomics's recent performance shows its demand has slowed significantly as its annualized revenue growth of 6.5% over the last two years was well below its five-year trend. We can dig further into the company's revenue dynamics by analyzing its most important segment, Consumables. Over the last two years, 10x Genomics's Consumables revenue (recurring orders) averaged 3.7% year-on-year growth. This segment has lagged the company's overall sales. This quarter, 10x Genomics reported year-on-year revenue growth of 12.9%, and its $172.9 million of revenue exceeded Wall Street's estimates by 24%. Company management is currently guiding for a 6.4% year-on-year decline in sales next quarter. Looking further ahead, sell-side analysts expect revenue to decline by 7.6% over the next 12 months, a deceleration versus the last two years. This projection is underwhelming and indicates its products and services will see some demand headwinds. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Operating Margin Although 10x Genomics was profitable this quarter from an operational perspective, it's generally struggled over a longer time period. Its expensive cost structure has contributed to an average operating margin of negative 42.4% over the last five years. Unprofitable healthcare companies require extra attention because they could get caught swimming naked when the tide goes out. It's hard to trust that the business can endure a full cycle. On the plus side, 10x Genomics's operating margin rose over the last five years, as its sales growth gave it operating leverage. Zooming in on its more recent performance, we can see the company's trajectory is intact as its margin has also increased by 15.8 percentage points on a two-year basis. This quarter, 10x Genomics generated an operating margin profit margin of 17.4%, up 44.7 percentage points year on year. This increase was a welcome development and shows it was more efficient. Earnings Per Share Revenue trends explain a company's historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions. Although 10x Genomics's full-year earnings are still negative, it reduced its losses and improved its EPS by 7.4% annually over the last five years. The next few quarters will be critical for assessing its long-term profitability. In Q2, 10x Genomics reported EPS at $0.28, up from negative $0.32 in the same quarter last year. This print easily cleared analysts' estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects 10x Genomics to perform poorly. Analysts forecast its full-year EPS of negative $0.70 will tumble to negative $1.01. Key Takeaways from 10x Genomics's Q2 Results We were impressed by how significantly 10x Genomics blew past analysts' EPS expectations this quarter. We were also excited its revenue outperformed Wall Street's estimates by a wide margin. On the other hand, its revenue guidance for next quarter missed. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 7.9% to $13.79 immediately following the results. 10x Genomics had an encouraging quarter, but one earnings result doesn't necessarily make the stock a buy. Let's see if this is a good investment. If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data